Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S. Seaman, Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew, Josh Mathews, Arshdeep Singh, Caitlin Marino, James Regan, Rockib Uddin, Manish C. Choudhary, James P. Flynn, Geoffrey Chen, Ashley M. Stuckwisch, Taryn Lipiner, Autumn Kittilson, Meghan Melberg, Rebecca F. Gilbert, Zahra Reynolds, Surabhi L. Iyer, Grace C. Chamberlin, Tammy D. Vyas, Jatin M. Vyas, Marcia B. Goldberg, View ORCID ProfileJeremy Luban, Jonathan Z. Li, Amy K. Barczak, View ORCID ProfileJacob E. Lemieux
doi: https://doi.org/10.1101/2022.03.02.22271731
Michael S. Seaman
1Beth Israel Deaconess Medical Center, Boston, MA
2Harvard Medical School, Boston, MA
Mark J. Siedner
3Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA
Julie Boucau
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
2Harvard Medical School, Boston, MA
Christy L. Lavine
1Beth Israel Deaconess Medical Center, Boston, MA
Fadi Ghantous
1Beth Israel Deaconess Medical Center, Boston, MA
May Y. Liew
3Massachusetts General Hospital, Boston, MA, USA
Josh Mathews
3Massachusetts General Hospital, Boston, MA, USA
Arshdeep Singh
3Massachusetts General Hospital, Boston, MA, USA
Caitlin Marino
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
James Regan
5Brigham and Women’s Hospital Boston, MA, USA
Rockib Uddin
3Massachusetts General Hospital, Boston, MA, USA
Manish C. Choudhary
5Brigham and Women’s Hospital Boston, MA, USA
James P. Flynn
5Brigham and Women’s Hospital Boston, MA, USA
Geoffrey Chen
3Massachusetts General Hospital, Boston, MA, USA
Ashley M. Stuckwisch
3Massachusetts General Hospital, Boston, MA, USA
Taryn Lipiner
3Massachusetts General Hospital, Boston, MA, USA
Autumn Kittilson
5Brigham and Women’s Hospital Boston, MA, USA
Meghan Melberg
5Brigham and Women’s Hospital Boston, MA, USA
Rebecca F. Gilbert
3Massachusetts General Hospital, Boston, MA, USA
Zahra Reynolds
3Massachusetts General Hospital, Boston, MA, USA
Surabhi L. Iyer
3Massachusetts General Hospital, Boston, MA, USA
Grace C. Chamberlin
3Massachusetts General Hospital, Boston, MA, USA
Tammy D. Vyas
3Massachusetts General Hospital, Boston, MA, USA
Jatin M. Vyas
3Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA
Marcia B. Goldberg
3Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA
Jeremy Luban
6UMass Med School, Worcester, MA, USA
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
7Broad Institute, Cambridge, MA, USA
Jonathan Z. Li
5Brigham and Women’s Hospital Boston, MA, USA
Amy K. Barczak
3Massachusetts General Hospital, Boston, MA, USA
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Jacob E. Lemieux
2Harvard Medical School, Boston, MA
3Massachusetts General Hospital, Boston, MA, USA
7Broad Institute, Cambridge, MA, USA
Article usage
Posted March 03, 2022.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S. Seaman, Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew, Josh Mathews, Arshdeep Singh, Caitlin Marino, James Regan, Rockib Uddin, Manish C. Choudhary, James P. Flynn, Geoffrey Chen, Ashley M. Stuckwisch, Taryn Lipiner, Autumn Kittilson, Meghan Melberg, Rebecca F. Gilbert, Zahra Reynolds, Surabhi L. Iyer, Grace C. Chamberlin, Tammy D. Vyas, Jatin M. Vyas, Marcia B. Goldberg, Jeremy Luban, Jonathan Z. Li, Amy K. Barczak, Jacob E. Lemieux
medRxiv 2022.03.02.22271731; doi: https://doi.org/10.1101/2022.03.02.22271731
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S. Seaman, Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew, Josh Mathews, Arshdeep Singh, Caitlin Marino, James Regan, Rockib Uddin, Manish C. Choudhary, James P. Flynn, Geoffrey Chen, Ashley M. Stuckwisch, Taryn Lipiner, Autumn Kittilson, Meghan Melberg, Rebecca F. Gilbert, Zahra Reynolds, Surabhi L. Iyer, Grace C. Chamberlin, Tammy D. Vyas, Jatin M. Vyas, Marcia B. Goldberg, Jeremy Luban, Jonathan Z. Li, Amy K. Barczak, Jacob E. Lemieux
medRxiv 2022.03.02.22271731; doi: https://doi.org/10.1101/2022.03.02.22271731
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)